ArticleEuropean heart journal. Imaging methods and practice2026
ΔVExPLUs: prognostic value of integrating serial changes in VExUS score and lung ultrasound in acute decompensated heart failure.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From prognostication to implementation: the next frontier for ultrasound-guided assessment of decongestion.European heart journal. Imaging methods and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To investigate whether early combined changes in venous excess ultrasound (VExUS) and lung ultrasound (LUS) were associated with outcomes in acute decompensated heart failure (ADHF). Methods and results: We prospectively enrolled 104 patients with ADHF [mean age 64.3 ± 13.5 years, 69.2% male, median left ventricle ejection fraction 24.5% (18.0, 32.0)]. VExUS score and LUS were performed within 24 h of admission and after 72 h. Changes in congestion were integrated into a single metric (ΔVExPLUs = [2 × ΔVExUS] + ΔLUS), with ΔVExUS multiplied by two to balance its narrower scoring range. The primary outcome was in-hospital mortality. Secondary outcomes included 30-day all-cause mortality and a composite of 30-day all-cause mortality, heart transplantation and left ventricular assist device implantation. Patients with greater ΔVExPLUs improvement had lower rates of in-hospital mortality (3% vs. 46%; Conclusion: Serial integration of systemic and pulmonary ultrasound parameters through ΔVExPLUs is independently associated with short-term outcomes in ADHF and may improve early risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.